Cancer runs in my family. How can I cut my risk?
Cancer Center expert featured in New York Times article
The University of Cincinnati Cancer Center's Syed Ahmad was featured in a New York Times article discussing ways to reduce your risk of cancer when it runs in your family.
Ahmad said patients may be referred to a genetic specialist to check for gene changes that increase your risk if your doctor deems it necessary.
“A lot of times, patients are scared to go to a genetic counselor” because of “fear of the unknown,” said Ahmad, interim director of the Cancer Center, professor, Hayden Family Endowed Chair for Cancer Research, section chief of surgical oncology and vice chair for faculty development in the Department of Surgery in UC's College of Medicine.
Ahmad added that having genetic variants doesn't guarantee you will develop cancer. But common genes tested for include the BRCA1 and BRCA2 genes if several family members have had breast cancer, or Lynch syndrome if multiple relatives have had colon cancer. Lynch syndrome is an inheritable genetic condition that can increase colon cancer risk by up to 80% for men and 60% for women.
Read the New York Times article.
Featured photo at top of Dr. Ahmad. Photo/University of Cincinnati Cancer Center.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.